Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses
- PMID: 33879453
- PMCID: PMC8914241
- DOI: 10.1158/1055-9965.EPI-20-1690
Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses
Abstract
Background: Epidemiologic studies evaluating associations between sex steroid hormones and colorectal cancer risk have yielded inconsistent results. To elucidate the role of circulating levels of testosterone, and sex hormone-binding globulin (SHBG) in colorectal cancer risk, we conducted observational and Mendelian randomization (MR) analyses.
Methods: The observational analyses included 333,530 participants enrolled in the UK Biobank with testosterone and SHBG measured. HRs and 95% confidence intervals (CI) were estimated using multivariable Cox proportional hazards models. For MR analyses, genetic variants robustly associated with hormone levels were identified and their association with colorectal cancer (42,866 cases/42,752 controls) was examined using two-sample MR.
Results: In the observational analysis, there was little evidence that circulating levels of total testosterone were associated with colorectal cancer risk; the MR analyses showed a greater risk for women (OR per 1-SD = 1.09; 95% CI, 1.01-1.17), although pleiotropy may have biased this result. Higher SHBG concentrations were associated with greater colorectal cancer risk for women (HR per 1-SD = 1.16; 95% CI, 1.05-1.29), but was unsupported by the MR analysis. There was little evidence of associations between free testosterone and colorectal cancer in observational and MR analyses.
Conclusions: Circulating concentrations of sex hormones are unlikely to be causally associated with colorectal cancer. Additional experimental studies are required to better understand the possible role of androgens in colorectal cancer development.
Impact: Our results from large-scale analyses provide little evidence for sex hormone pathways playing a causal role in colorectal cancer development.See related commentary by Hang and Shen, p. 1302.
©2021 American Association for Cancer Research.
Conflict of interest statement
Figures
Comment in
-
Sex Hormone and Colorectal Cancer: The Knowns and Unknowns.Cancer Epidemiol Biomarkers Prev. 2021 Jul;30(7):1302-1304. doi: 10.1158/1055-9965.EPI-21-0472. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34210680
Similar articles
-
Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses.Br J Cancer. 2021 Oct;125(9):1308-1317. doi: 10.1038/s41416-021-01518-3. Epub 2021 Aug 6. Br J Cancer. 2021. PMID: 34363033 Free PMC article.
-
[Genetic Causation Analysis of Hyperandrogenemia Testing Indicators and Preeclampsia].Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 May 20;55(3):566-573. doi: 10.12182/20240560106. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38948277 Free PMC article. Chinese.
-
Genetically predicted sex hormone levels and health outcomes: phenome-wide Mendelian randomization investigation.Int J Epidemiol. 2022 Dec 13;51(6):1931-1942. doi: 10.1093/ije/dyac036. Int J Epidemiol. 2022. PMID: 35218343 Free PMC article.
-
Circulating Sex Hormones Are Associated With Gastric and Colorectal Cancers but Not Esophageal Adenocarcinoma in the UK Biobank.Am J Gastroenterol. 2021 Mar 1;116(3):522-529. doi: 10.14309/ajg.0000000000001045. Am J Gastroenterol. 2021. PMID: 33156012 Free PMC article.
-
Non-genetic biomarkers and colorectal cancer risk: Umbrella review and evidence triangulation.Cancer Med. 2020 Jul;9(13):4823-4835. doi: 10.1002/cam4.3051. Epub 2020 May 12. Cancer Med. 2020. PMID: 32400092 Free PMC article.
Cited by
-
Sex hormones and risk of lung and colorectal cancers in women: a Mendelian randomization study.Sci Rep. 2024 Oct 12;14(1):23891. doi: 10.1038/s41598-024-75305-4. Sci Rep. 2024. PMID: 39396092 Free PMC article.
-
Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis.JNCI Cancer Spectr. 2021 Sep 28;5(6):pkab084. doi: 10.1093/jncics/pkab084. eCollection 2021 Dec. JNCI Cancer Spectr. 2021. PMID: 34805742 Free PMC article.
-
Role of sex steroids in colorectal cancer: pathomechanisms and medical applications.Am J Cancer Res. 2024 Jul 15;14(7):3200-3221. doi: 10.62347/OEBS6893. eCollection 2024. Am J Cancer Res. 2024. PMID: 39113870 Free PMC article. Review.
-
Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.Cancer Causes Control. 2023 Nov;34(11):949-961. doi: 10.1007/s10552-023-01736-5. Epub 2023 Jun 21. Cancer Causes Control. 2023. PMID: 37341814 Free PMC article.
-
Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men.Clin Endocrinol (Oxf). 2022 Dec;97(6):792-803. doi: 10.1111/cen.14803. Epub 2022 Aug 8. Clin Endocrinol (Oxf). 2022. PMID: 35902376 Free PMC article.
References
-
- Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017;66:683–91 - PubMed
-
- McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 1980;65:1201–7 - PubMed
-
- Lin KJ, Cheung WY, Lai JY, Giovannucci EL. The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer 2012;130:419–30 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA067941/CA/NCI NIH HHS/United States
- U01 HG004438/HG/NHGRI NIH HHS/United States
- U01 HG004446/HG/NHGRI NIH HHS/United States
- K05 CA154337/CA/NCI NIH HHS/United States
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- P01 CA196569/CA/NCI NIH HHS/United States
- R01 CA059045/CA/NCI NIH HHS/United States
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- R01 CA197350/CA/NCI NIH HHS/United States
- R01 CA076366/CA/NCI NIH HHS/United States
- C8221/A29017/CRUK_/Cancer Research UK/United Kingdom
- R35 CA197735/CA/NCI NIH HHS/United States
- MC_PC_17228/MRC_/Medical Research Council/United Kingdom
- U01 CA067941/CA/NCI NIH HHS/United States
- U01 CA182883/CA/NCI NIH HHS/United States
- U10 CA037429/CA/NCI NIH HHS/United States
- R01 CA114347/CA/NCI NIH HHS/United States
- R01 CA072520/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- P30 CA015704/CA/NCI NIH HHS/United States
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- P30 CA006973/CA/NCI NIH HHS/United States
- U24 CA074783/CA/NCI NIH HHS/United States
- 19167/CRUK_/Cancer Research UK/United Kingdom
- P01 CA055075/CA/NCI NIH HHS/United States
- S10 OD028685/OD/NIH HHS/United States
- R01 CA151993/CA/NCI NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- P30 DK034987/DK/NIDDK NIH HHS/United States
- R01 CA048998/CA/NCI NIH HHS/United States
- U01 CA137088/CA/NCI NIH HHS/United States
- C18281/A29019/CRUK_/Cancer Research UK/United Kingdom
- R01 CA189184/CA/NCI NIH HHS/United States
- U01 CA167552/CA/NCI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- MR/N003284/1/MRC_/Medical Research Council/United Kingdom
- Z01 CP010200/ImNIH/Intramural NIH HHS/United States
- U24 CA074794/CA/NCI NIH HHS/United States
- R01 CA066635/CA/NCI NIH HHS/United States
- C490/A16561/CRUK_/Cancer Research UK/United Kingdom
- U01 CA206110/CA/NCI NIH HHS/United States
- 1000143/MRC_/Medical Research Council/United Kingdom
- R01 CA244588/CA/NCI NIH HHS/United States
- HHSN268201200008C/HL/NHLBI NIH HHS/United States
- R01 CA137178/CA/NCI NIH HHS/United States
- U01 CA074794/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- U01 CA167551/CA/NCI NIH HHS/United States
- P30 CA076292/CA/NCI NIH HHS/United States
- 29019/CRUK_/Cancer Research UK/United Kingdom
- P30 CA014089/CA/NCI NIH HHS/United States
- G0401527/MRC_/Medical Research Council/United Kingdom
- R01 CA081488/CA/NCI NIH HHS/United States
- HHSN271201100004C/AG/NIA NIH HHS/United States
- R01 CA201407/CA/NCI NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- P01 CA033619/CA/NCI NIH HHS/United States
- U01 CA086308/CA/NCI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- MR/M012190/1/MRC_/Medical Research Council/United Kingdom
- HHSN268201100002C/WH/WHI NIH HHS/United States
- R01 CA207371/CA/NCI NIH HHS/United States
- R03 CA153323/CA/NCI NIH HHS/United States
- G1000143/MRC_/Medical Research Council/United Kingdom
- R01 CA042182/CA/NCI NIH HHS/United States
- C588/A19167/CRUK_/Cancer Research UK/United Kingdom
- HHSN261201700006I/CA/NCI NIH HHS/United States
- R01 CA060987/CA/NCI NIH HHS/United States
- T32 ES013678/ES/NIEHS NIH HHS/United States
- R01 CA136726/CA/NCI NIH HHS/United States
- 25004/CRUK_/Cancer Research UK/United Kingdom
- P30 CA016058/CA/NCI NIH HHS/United States
- 14136/CRUK_/Cancer Research UK/United Kingdom
- KL2 TR002317/TR/NCATS NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- K05 CA152715/CA/NCI NIH HHS/United States
- U01 CA122839/CA/NCI NIH HHS/United States
- HHSN261201500005C/CA/NCI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- U01 CA074783/CA/NCI NIH HHS/United States
- U01 CA084968/CA/NCI NIH HHS/United States
- KL2 TR000421/TR/NCATS NIH HHS/United States
- 001/WHO_/World Health Organization/International
- P50 CA127003/CA/NCI NIH HHS/United States
- UM1 CA182883/CA/NCI NIH HHS/United States
- K07 CA190673/CA/NCI NIH HHS/United States
- HHSN268201200008I/HL/NHLBI NIH HHS/United States
- HHSN268201100001C/WH/WHI NIH HHS/United States
- Z01 CP010200/CP/NCI NIH HHS/United States
- R37 CA054281/CA/NCI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- R01 CA097325/CA/NCI NIH HHS/United States
- U19 CA148107/CA/NCI NIH HHS/United States
- MC_QA137853/MRC_/Medical Research Council/United Kingdom
- U01 AG018033/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
